title: Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
authors.affiliation: MedImmune Vaccines Inc., 297 N. Bernerdo Avenue, Mountain View, CA 94043, USA. tangr@medimmune.com
authors.forename: Roderick S
authors.initials: RS
authors.lastname: Tang
authors.forename: Mia
authors.initials: M
authors.lastname: MacPhail
authors.forename: Jeanne H
authors.initials: JH
authors.lastname: Schickli
authors.forename: Jasmine
authors.initials: J
authors.lastname: Kaur
authors.forename: Christopher L
authors.initials: CL
authors.lastname: Robinson
authors.forename: Heather A
authors.initials: HA
authors.lastname: Lawlor
authors.forename: Jeanne M
authors.initials: JM
authors.lastname: Guzzetta
authors.forename: Richard R
authors.initials: RR
authors.lastname: Spaete
authors.forename: Aurelia A
authors.initials: AA
authors.lastname: Haller
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D002522:Chlorocebus aethiops; D005822:Genetic Vectors; D006801:Humans; D010224:Parainfluenza Virus 3, Human / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D022261:Respiratory Syncytial Virus Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D018113:Respiratory Syncytial Virus, Human / Q000276:immunology / Q000472:pathogenicity; D012137:Respiratory System / Q000821:virology; D012995:Solubility; D014611:Vaccination; D014709:Vero Cells; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D014779:Virus Replication
chemical_list: D000914:Antibodies, Viral; D022261:Respiratory Syncytial Virus Vaccines; D014764:Viral Proteins